STUDY OF DEMOGRAPHIC ANALYSIS, CLINICAL CHARACTERISTICS, DIAGNOSIS, MANAGEMENT AND COMPLICATIONS IN COVID-19 PATIENTS
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i12.43085Keywords:
COVID-19, Fever, Cough, High-resolution computed tomography, Reverse transcription polymerase chain reaction, Hypertension, Corticosteroids, Interleukin-6, ImmunosuppressantAbstract
Objective: To study the demographic analysis, clinical characteristics, diagnosis, and management in covid-19 patients. To assess the complications in covid-19 patients.
Methods: A retrospective observational single centered study is carried out to study the demographic analysis, clinical characteristics, diagnosis, management, and complications in covid-19 patients.
Results: Among 100 covid-19 patients 58% were male and 42% were female. Percentages of age group between 60-70 years (27%), 50-60 (20%), 40-50 (16%), 70-80 (16%), 30-40 (8%), 20-30 (5%), 80-90 (4%), and 10-20 (4%). Co-morbidities were diabetes (44%), hypertension (28%), CAD (21%), thyroid (19%), COPD (12%), anemia (8%), and renal impairment (4%). Signs and symptoms were fever (88%), cough (80%), SOB (72%), fatigue (68%), myalgia (60%), loss of appetite (52%), cold (24%), loss of smell and taste (20%), diarrhea and vomiting (12%). (97%) of the patients had two or more symptoms. Diagnostic test include RT-PCR (100%), HRCT (100%), O2 saturation (99%), D-dimer (65%), c-reactive (60%), Procalcitonin (60%), and also LDH, IL-6,PT, INR, ferritin, CBP, WBC. Treatment includes antiviral (100%), antibiotics (100%), corticosteroids (73%), immunosuppressant (54%), and antihypertensive, antidiabetic, Antiplatelets, bronchodilators, vitamins, and mineral supplements.
Conclusion: Covid-19 infects the males more and average ages of 65 years are at risk. Hypertension and diabetes were most common co-morbid condition. Fever and cough are major followed by weakness sob and cold. RT- PCR and HRCT are accurate tool to detect covid-19. Although standard treatment is not yet available antibiotics and antiviral are used followed by corticosteroids. Majority of the patients have mild and moderate injection and with the lowest death rate. Older age and co-morbid conditions are major risk factors.
Downloads
References
Sheydaei M, Alinia-Ahandani E. Overview of the novel coronavirus introduction (Covid19): A review. Med Sci J 2020;6:14-20.
The Indigenous EXPRESS December 2020, Wondering what the Latest Strain of the Corona Virus is? The Doctor Said that, on the 11 January 2021, “New Delhi,” a Doctor had seen. Available from: https:// indianexpress.com/art/lifestyle/health-new-coronavirus-strain-doctor-explanations-7119843
Yuki K, Koutsogiannaki S. Pathophysiology COVID-19: A review. Clin Immunol 2020;215:108427.
Azin T. Arbabi M, Farsi Y, Jamshidi P, Hasanzadeh S, Calcagno MJ, et al. Clinical characteristics, diagnosis, and management of COVID-19 in patients in the hospital: Systematic analysis of case reports and case series. Med Front 2020;7:231.
Sahebnasagh A, Avan R, Saghafi F, Mojtahedzadeh M, Sadremomtaz M, Tanzifi A, et al. COVID-19 pharmacological therapies. Pharmacol Rep 2020;20:1-33.
Azer SA. COVID-19: Pathophysiology, diagnosis, complications and research therapy. New Microbs New Infect 2020;37:100738. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, aetiology, clinical manifestosis and diagnosis, coronavirus disease prevention and control (COVID-19) during the early outbreak: A scope study. Infect Dis Poverty 2020;9:29.
Casas-Rojo JM, Antón-Santos JM, Cortés JM, Lumbreras-Bermejo C, Ramos-Rincón JM, Roy-Vallejo E, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry. Rev Clin Esp 2020;220:480-94. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course and results of persons in New York city who suffer from serious illnesses with COVID-19: Future cohort research. Lancet 2020;395:1763-70.
Huang I, Lim MA, Pranata R. Increased mortality and severity of illness in COVID 19 pneumonia a comprehensive review, meta-analysis and meta-regression are connected with diabetes mellitus. Diabetes Metab Syndr 2020;14:395-403.
Published
How to Cite
Issue
Section
Copyright (c) 2021 M PAVAN KUMAR
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.